Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.
Epidermal growth factor-urogastrone (EGF-URO) administered intraarterially was a potent dilator in dog femoral (FEM), superior (cephalic) mesenteric (SMA), celiac (CAC), coronary (COR), carotid (CAR), and renal (REN) vascular beds. The effects of EGF-URO, which exhibited tachyphylaxis, could not be...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3496362/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113048 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|